There is some evidence that inhibition of CTLA-4 increases Th17 CD4+ cells in the peripheral blood [9], and there is also evidence that tissue samples consistent with sarcoidosis show increased infiltration of Th17 effector CD4+ cells in tissue [10]. Here, CTLA4 is linked to sarcoidosis.